Extracellular vesicles and their translational therapeutic potential: Original scientific article

Riya  Mukherjee; Ramendra Pati  Pandey; Chung Ming  Chang

doi:10.5599/admet.3328

Authors

Riya Mukherjee Graduate Institute of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan https://orcid.org/0000-0003-3796-4586
Ramendra Pati Pandey School of Biosciences and Bioengineering, D Y Patil International University, Akurdi, Pune, India https://orcid.org/0000-0002-5196-6468
Chung Ming Chang Master & PhD program in Biotechnology Industry, Chang Gung University https://orcid.org/0000-0002-8484-6905

DOI:

https://doi.org/10.5599/admet.3328

Keywords:

Mesenchymal stem cell-derived extracellular vesicles, osteoarthritis therapy, preclinical models, cartilage regeneration, regenerative medicine

Abstract

Background and purpose: Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as a promising cell-free therapy for osteoarthritis (OA). However, their transition into clinical therapeutics is constrained by unstandardized pharmacokinetics and heterogeneous preclinical reporting. Experimental approach: A meta-analysis of preclinical in vivo OA models evaluating MSC-EV therapy was conducted. Study quality was rigorously assessed using MISEV 2023 (Minimal Information for Studies of Extracellular Vesicles, 2023) criteria and the SYRCLE (Systematic Review Centre for Laboratory animal Experimentation) risk-of-bias tool. Quantitative synthesis was performed for the Osteoarthritis Research Society International (OARSI) histological score, reporting pooled mean differences (MDs) and 95 % confidence intervals (95% CIs), along with heterogeneity (I² statistic) and microRNA (miRNA) cargo analysis. Key results: MSC-EV administration conferred robust structural protection against cartilage degradation. Quantitative synthesis of human-derived MSC-EVs (26 studies) significantly reduced OARSI scores (MD -3.27, 95% CI -4.66 to -1.88; p < 0.0001). Similarly, quantitative synthesis of animal-derived MSC-EVs (8 studies) demonstrated an even more profound effect (MD -5.58, 95% CI -7.13 to -4.03; p < 0.0001). Non-parametric Trim-and-Fill analysis estimated zero missing studies in both datasets, confirming that these effect sizes are highly robust to publication bias. Despite these robust efficacy signals, significant heterogeneity (I² > 84 %) persisted. Meta-regression revealed that arbitrary dosage metrics, whether reported by particle count or protein concentration, failed to reliably predict treatment efficacy, highlighting severe gaps in dose-exposure standardization. Conclusion: MSC-EVs demonstrate highly potent, cross-species efficacy in attenuating OA progression. However, clinical translation is critically bottlenecked by a lack of ADMET (absorption, distribution, metabolism, excretion and toxicity) compliance. Future research must prioritize standardized particle-based dosing, in vivo pharmacokinetic tracking, and rigorous cargo-function validation to enable regulatory approval.

Downloads

Download data is not yet available.

References

Cao, H., Chen, M., Cui, X., Liu, Y., Liu, Y., Deng, S., Yuan, T., Fan, Y., Wang, Q., & Zhang, X. (2023). Cell-Free Osteoarthritis Treatment with Sustained-Release of Chondrocyte-Targeting Exosomes from Umbilical Cord-Derived Mesenchymal Stem Cells to Rejuvenate Aging Chondrocytes. ACS Nano, 17(14), 13358–13376. https://doi.org/10.1021/acsnano.3c01612 DOI: https://doi.org/10.1021/acsnano.3c01612

Chang, L. H., Wu, S. C., Chen, C. H., Chen, J. W., Huang, W. C., Wu, C. W., Lin, Y. S., Chen, Y. J., Chang, J. K., & Ho, M. L. (2023). Exosomes Derived from Hypoxia-Cultured Human Adipose Stem Cells Alleviate Articular Chondrocyte Inflammaging and Post-Traumatic Osteoarthritis Progression. International Journal of Molecular Sciences, 24(17). https://doi.org/10.3390/ijms241713414 DOI: https://doi.org/10.3390/ijms241713414

Chen, P., Tang, S., Gao, H., Zhang, H., Chen, C., Fang, Z., Peng, G., Weng, H., Chen, A., Zhang, C., Qiu, Z., Li, S., Chen, J., Chen, L., & Chen, X. (2022). Wharton’s jelly mesenchymal stem cell-derived small extracellular vesicles as natural nanoparticles to attenuate cartilage injury via microRNA regulation. International Journal of Pharmaceutics, 623(February), 121952. https://doi.org/10.1016/j.ijpharm.2022.121952 DOI: https://doi.org/10.1016/j.ijpharm.2022.121952

Copp, G., Robb, K. P., & Viswanathan, S. (2023). Culture-expanded mesenchymal stromal cell therapy: does it work in knee osteoarthritis? A pathway to clinical success. Cellular and Molecular Immunology, 20(6), 626–650. https://doi.org/10.1038/S41423-023-01020-1;SUBJMETA DOI: https://doi.org/10.1038/s41423-023-01020-1

Cosenza, S., Ruiz, M., Toupet, K., Jorgensen, C., & Noël, D. (2017). Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Scientific Reports, 7(1), 1–12. https://doi.org/10.1038/s41598-017-15376-8 DOI: https://doi.org/10.1038/s41598-017-15376-8

Duan, A., Shen, K., Li, B., Li, C., Zhou, H., Kong, R., Shao, Y., Qin, J., Yuan, T., Ji, J., Guo, W., Wang, X., Xue, T., Li, L., Huang, X., Sun, Y., Cai, Z., Liu, W., & Liu, F. (2021). Extracellular vesicles derived from LPS-preconditioned human synovial mesenchymal stem cells inhibit extracellular matrix degradation and prevent osteoarthritis of the knee in a mouse model. Stem Cell Research and Therapy, 12(1), 1–20. https://doi.org/10.1186/s13287-021-02507-2 DOI: https://doi.org/10.1186/s13287-021-02507-2

Ehab, S., Gaser, O. A., Oyouni, A. A. A., Kameli, N., Alzahrani, F., & Abdal Dayem, A. (2025). Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology, 17(4), e70031. https://doi.org/10.1002/WNAN.70031 DOI: https://doi.org/10.1002/wnan.70031

Fazaeli, H., Kalhor, N., Naserpour, L., Davoodi, F., Sheykhhasan, M., Hosseini, S. K. E., Rabiei, M., & Sheikholeslami, A. (2021). A Comparative Study on the Effect of Exosomes Secreted by Mesenchymal Stem Cells Derived from Adipose and Bone Marrow Tissues in the Treatment of Osteoarthritis-Induced Mouse Model. BioMed Research International, 2021. https://doi.org/10.1155/2021/9688138 DOI: https://doi.org/10.1155/2021/9688138

Figueroa-Valdés, A. I., Luz-Crawford, P., Herrera-Luna, Y., Georges-Calderón, N., García, C., Tobar, H. E., Araya, M. J., Matas, J., Donoso-Meneses, D., de la Fuente, C., Cuenca, J., Parra, E., Lillo, F., Varela, C., Cádiz, M. I., Vernal, R., Ortloff, A., Nardocci, G., Castañeda, V., … Alcayaga-Miranda, F. (2025). Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis. Journal of Nanobiotechnology, 23(1), 13. https://doi.org/10.1186/s12951-024-03088-x DOI: https://doi.org/10.1186/s12951-024-03088-x

Fu, Y., Cui, S., Zhou, Y., & Qiu, L. (2023). Dental Pulp Stem Cell-Derived Exosomes Alleviate Mice Knee Osteoarthritis by Inhibiting TRPV4-Mediated Osteoclast Activation. International Journal of Molecular Sciences, 24(5). https://doi.org/10.3390/ijms24054926 DOI: https://doi.org/10.3390/ijms24054926

González-Rodríguez, A., De Toro, F. J., Jorge-Mora, A., Fernandez-Pernas, P., Rivadulla, C. P., Fraga, M., Fafián-Labora, J. A., & Arufe, M. C. (2025). Targeting osteoarthritis with small extracellular vesicle therapy: potential and perspectives. Frontiers in Bioengineering and Biotechnology, 13, 1570526. https://doi.org/10.3389/FBIOE.2025.1570526/FULL DOI: https://doi.org/10.3389/fbioe.2025.1570526

Haddaway, N. R., Page, M. J., Pritchard, C. C., & McGuinness, L. A. (2022). PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Systematic Reviews, 18(2), e1230. https://doi.org/10.1002/CL2.1230 DOI: https://doi.org/10.1002/cl2.1230

He, L., He, T., Xing, J., Zhou, Q., Fan, L., Liu, C., Chen, Y., Wu, D., Tian, Z., Liu, B., & Rong, L. (2020). Bone marrow mesenchymal stem cell-derived exosomes protect cartilage damage and relieve knee osteoarthritis pain in a rat model of osteoarthritis. Stem Cell Research and Therapy, 11(1), 1–15. https://doi.org/10.1186/s13287-020-01781-w DOI: https://doi.org/10.1186/s13287-020-01781-w

Hsueh, Y. H., Buddhakosai, W., Le, P. N., Tu, Y. Y., Huang, H. C., Lu, H. E., Chen, W. L., & Tu, Y. K. (2023). Therapeutic effect of induced pluripotent stem cell -derived extracellular vesicles in an in vitro and in vivo osteoarthritis model. Journal of Orthopaedic Translation, 38(August 2022), 141–155. https://doi.org/10.1016/j.jot.2022.10.004 DOI: https://doi.org/10.1016/j.jot.2022.10.004

Hu, J., Shi, Z. S., Liu, X. Z., Cai, H. T., Yang, A. F., Sun, D. M., Xu, L. L., Yang, Y., & Li, Z. H. (2022). Exosomes Derived from Runx2-Overexpressing BMSCs Enhance Cartilage Tissue Regeneration and Prevent Osteoarthritis of the Knee in a Rabbit Model. Stem Cells International, 2022. https://doi.org/10.1155/2022/6865041 DOI: https://doi.org/10.1155/2022/6865041

Huang, C., Zhao, Y., Lin, S., Li, L., Guo, X., Yumiseba, S., Yang, J. dar, Hariri, R., Ye, Q., He, S., & Kilcoyne, A. (2023). Characterization of human placenta-derived exosome (pExo) as a potential osteoarthritis disease modifying therapeutic. Arthritis Research and Therapy, 25(1), 1–12. https://doi.org/10.1186/s13075-023-03219-z DOI: https://doi.org/10.1186/s13075-023-03219-z

Jin, Y., Xu, M., Zhu, H., Dong, C., Ji, J., Liu, Y., Deng, A., & Gu, Z. (2021). Therapeutic effects of bone marrow mesenchymal stem cells-derived exosomes on osteoarthritis. Journal of Cellular and Molecular Medicine, 25(19), 9281–9294. https://doi.org/10.1111/JCMM.16860 DOI: https://doi.org/10.1111/jcmm.16860

Langworthy, M., Dasa, V., & Spitzer, A. I. (2024). Knee osteoarthritis: disease burden, available treatments, and emerging options. Therapeutic Advances in Musculoskeletal Disease, 16. https://doi.org/10.1177/1759720X241273009 DOI: https://doi.org/10.1177/1759720X241273009

Lee, K. S., Lee, J., Kim, H. K., Yeom, S. H., Woo, C. H., Jung, Y. J., Yun, Y. E., Park, S. Y., Han, J., Kim, E., Sul, J. H., Jung, J. M., Park, J. H., Choi, J. S., Cho, Y. W., & Jo, D. G. (2021). Extracellular vesicles from adipose tissue-derived stem cells alleviate osteoporosis through osteoprotegerin and miR-21-5p. Journal of Extracellular Vesicles, 10(12). https://doi.org/10.1002/jev2.12152 DOI: https://doi.org/10.1002/jev2.12152

Li, B., Shen, E., Wu, Z., Qi, H., Wu, C., Liu, D., & Jiang, X. (2024). BMSC-Derived Exosomes Attenuate Rat Osteoarthritis by Regulating Macrophage Polarization through PINK1/Parkin Signaling Pathway. Cartilage. https://doi.org/10.1177/19476035241245805 DOI: https://doi.org/10.21203/rs.3.rs-2614922/v1

Li, J., Ding, Z., Li, Y., Wang, W., Wang, J., Yu, H., Liu, A., Miao, J., Chen, S., Wu, T., & Cao, Y. (2020). BMSCs-Derived Exosomes Ameliorate Pain Via Abrogation of Aberrant Nerve Invasion in Subchondral Bone in Lumbar Facet Joint Osteoarthritis. Journal of Orthopaedic Research, 38(3), 670–679. https://doi.org/10.1002/jor.24497 DOI: https://doi.org/10.1002/jor.24497

Li, K., Yan, G., Huang, H., Zheng, M., Ma, K., Cui, X., Lu, D., Zheng, L., Zhu, B., Cheng, J., & Zhao, J. (2022). Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages. Journal of Nanobiotechnology, 20(1), 1–20. https://doi.org/10.1186/S12951-021-01236-1/TABLES/1 DOI: https://doi.org/10.1186/s12951-021-01236-1

Li, P., Lv, S., Jiang, W., Si, L., Liao, B., Zhao, G., Xu, Z., Wang, L., Zhang, J., Wu, H., Peng, Q., Li, Z., Qi, L., Chi, G., & Li, Y. (2022). Exosomes derived from umbilical cord mesenchymal stem cells protect cartilage and regulate the polarization of macrophages in osteoarthritis. Annals of Translational Medicine, 10(18), 976–976. https://doi.org/10.21037/ATM-22-3912 DOI: https://doi.org/10.21037/atm-22-3912

Liu, Y., Huang, K., Zhou, S. L., Li, S., Si, H. B., Zeng, Y., Xie, H. Q., & Shen, B. (2025). Engineered exosomal miR140 modulates mitophagy of chondrocytes through targeting CAPN1 to alleviate osteoarthritis. Science China Life Sciences, 68(9), 2617–2634. https://doi.org/10.1007/S11427-024-2843-7/METRICS DOI: https://doi.org/10.1007/s11427-024-2843-7

Liu, Y., Zeng, Y., Si, H. B., Tang, L., Xie, H. Q., & Shen, B. (2022). Exosomes Derived From Human Urine–Derived Stem Cells Overexpressing miR-140-5p Alleviate Knee Osteoarthritis Through Downregulation of VEGFA in a Rat Model. American Journal of Sports Medicine, 50(4), 1088–1105. https://doi.org/10.1177/03635465221073991 DOI: https://doi.org/10.1177/03635465221073991

Osteoarthritis. (n.d.). Retrieved September 18, 2025, from https://www.who.int/news-room/fact-sheets/detail/osteoarthritis?utm_source=chatgpt.com

Pan, X., Li, X., Zhang, L., Wu, F., Zhang, Q., Xu, S., Shen, C., Liang, J., & Pan, R. (2023). Umbilical cord mesenchymal stem cells relieve osteoarthritis in rats through immunoregulation and inhibition of chondrocyte apoptosis. Scientific Reports, 13(1), 1–9. https://doi.org/10.1038/s41598-023-42349-x DOI: https://doi.org/10.1038/s41598-023-42349-x

René, C. A., & Parks, R. J. (2024). Bioengineering extracellular vesicle cargo for optimal therapeutic efficiency. Molecular Therapy Methods and Clinical Development, 32(2). https://doi.org/10.1016/j.omtm.2024.101259 DOI: https://doi.org/10.1016/j.omtm.2024.101259

Selvadoss, A., Baby, H. M., Zhang, H., & Bajpayee, A. G. (2024). Harnessing exosomes for advanced osteoarthritis therapy. Nanoscale, 16(41), 19174–19191. https://doi.org/10.1039/D4NR02792B DOI: https://doi.org/10.1039/D4NR02792B

Shen, X., Qin, J., Wei, Z., & Liu, F. (2023). Bone marrow mesenchymal stem cell exosome-derived lncRNA TUC339 influences the progression of osteoarthritis by regulating synovial macrophage polarization and chondrocyte apoptosis. Biomedicine and Pharmacotherapy, 167, 115488. https://doi.org/10.1016/j.biopha.2023.115488 DOI: https://doi.org/10.1016/j.biopha.2023.115488

Shimomura, K., Wong, K. L., Saseendar, S., Muthu, S., Concaro, S., Fernandes, T. L., & Mahmood, A. (2024). Exploring the potential of mesenchymal stem/stromal cell-derived extracellular vesicles as cell-free therapy for osteoarthritis: a narrative review. Journal of Cartilage & Joint Preservation, 4(2), 100184. https://doi.org/10.1016/J.JCJP.2024.100184 DOI: https://doi.org/10.1016/j.jcjp.2024.100184

Steinmetz, J. D., Culbreth, G. T., Haile, L. M., Rafferty, Q., Lo, J., Fukutaki, K. G., Cruz, J. A., Smith, A. E., Vollset, S. E., Brooks, P. M., Cross, M., Woolf, A. D., Hagins, H., Abbasi-Kangevari, M., Abedi, A., Ackerman, I. N., Amu, H., Antony, B., Arabloo, J., … Kopec, J. A. (2023). Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. Rheumatology, 5(9), e508. https://doi.org/10.1016/S2665-9913(23)00163-7 DOI: https://doi.org/10.1016/S2665-9913(23)00163-7

Swami, P. N., Andriamifidy, H. F., Haque, S., Reed, T., Khan, A., & Grande, D. A. (2024). Exosomes from the synovial microenvironment in joint homeostasis and osteoarthritis. Journal of Cartilage and Joint Preservation, 4(4), 100220. https://doi.org/10.1016/j.jcjp.2024.100220 DOI: https://doi.org/10.1016/j.jcjp.2024.100220

Tang, S., Chen, P., Zhang, H., Weng, H., Fang, Z., Chen, C., Peng, G., Gao, H., Hu, K., Chen, J., Chen, L., & Chen, X. (2021). Comparison of Curative Effect of Human Umbilical Cord-Derived Mesenchymal Stem Cells and Their Small Extracellular Vesicles in Treating Osteoarthritis. International Journal of Nanomedicine, 16, 8185–8202. https://doi.org/10.2147/IJN.S336062 DOI: https://doi.org/10.2147/IJN.S336062

Tao, S. C., Yuan, T., Zhang, Y. L., Yin, W. J., Guo, S. C., & Zhang, C. Q. (2017). Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics, 7(1), 180–195. https://doi.org/10.7150/thno.17133 DOI: https://doi.org/10.7150/thno.17133

Wang, K., Li, F., Yuan, Y., Shan, L., Cui, Y., Qu, J., & Lian, F. (2020). Synovial Mesenchymal Stem Cell-Derived EV-Packaged miR-31 Downregulates Histone Demethylase KDM2A to Prevent Knee Osteoarthritis. Molecular Therapy Nucleic Acids, 22(37), 1078–1091. https://doi.org/10.1016/j.omtn.2020.09.014 DOI: https://doi.org/10.1016/j.omtn.2020.09.014

Wang, Y., Yu, D., Liu, Z., Zhou, F., Dai, J., Wu, B., Zhou, J., Heng, B. C., Zou, X. H., Ouyang, H., & Liu, H. (2017). Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Research and Therapy, 8(1), 1–13. https://doi.org/10.1186/s13287-017-0632-0 DOI: https://doi.org/10.1186/s13287-017-0632-0

Welsh, J. A., Goberdhan, D. C. I., O’Driscoll, L., Buzas, E. I., Blenkiron, C., Bussolati, B., Cai, H., Di Vizio, D., Driedonks, T. A. P., Erdbrügger, U., Falcon-Perez, J. M., Fu, Q. L., Hill, A. F., Lenassi, M., Lim, S. K., Mahoney, M. ỹ. G., Mohanty, S., Möller, A., Nieuwland, R., … Zubair, H. (2024). Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. Journal of Extracellular Vesicles, 13(2). https://doi.org/10.1002/JEV2.12404 DOI: https://doi.org/10.1002/jev2.12404

Woo, C. H., Kim, H. K., Jung, G. Y., Jung, Y. J., Lee, K. S., Yun, Y. E., Han, J., Lee, J., Kim, W. S., Choi, J. S., Yang, S., Park, J. H., Jo, D. G., & Cho, Y. W. (2020). Small extracellular vesicles from human adipose-derived stem cells attenuate cartilage degeneration. Journal of Extracellular Vesicles, 9(1). https://doi.org/10.1080/20013078.2020.1735249 DOI: https://doi.org/10.1080/20013078.2020.1735249

Wu, J., Kuang, L., Chen, C., Yang, J., Zeng, W. N., Li, T., Chen, H., Huang, S., Fu, Z., Li, J., Liu, R., Ni, Z., Chen, L., & Yang, L. (2019). miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials, 206(October 2018), 87–100. https://doi.org/10.1016/j.biomaterials.2019.03.022 DOI: https://doi.org/10.1016/j.biomaterials.2019.03.022

Xu, X., Liang, Y., Li, X., Ouyang, K., Wang, M., Cao, T., Li, W., Liu, J., Xiong, J., Li, B., Xia, J., Wang, D., & Duan, L. (2021). Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials, 269, 120539. https://doi.org/10.1016/J.BIOMATERIALS.2020.120539 DOI: https://doi.org/10.1016/j.biomaterials.2020.120539

Yan, L., Liu, G., & Wu, X. (2021). Exosomes derived from umbilical cord mesenchymal stem cells in mechanical environment show improved osteochondral activity via upregulation of LncRNA H19. Journal of Orthopaedic Translation, 26(March 2020), 111–120. https://doi.org/10.1016/j.jot.2020.03.005 DOI: https://doi.org/10.1016/j.jot.2020.03.005

Yang, H., Zhou, Y., Ying, B., Dong, X., Qian, Q., & Gao, S. (2024). Effects of human umbilical cord mesenchymal stem cell-derived exosomes in the rat osteoarthritis models. Stem Cells Translational Medicine, 13(8), 803–811. https://doi.org/10.1093/stcltm/szae031 DOI: https://doi.org/10.1093/stcltm/szae031

Zhang, J., Rong, Y., Luo, C., & Cui, W. (2020). Aging-V12I24-104110. 12(24), 25138–25152. DOI: https://doi.org/10.18632/aging.104110

Zhao, C., Chen, J. Y., Peng, W. M., Yuan, B., Bi, Q., & Xu, Y. J. (2020). Exosomes from adipose-derived stem cells promote chondrogenesis and suppress inflammation by upregulating miR-145 and miR-221. Molecular Medicine Reports, 21(4), 1881–1889. https://doi.org/10.3892/mmr.2020.10982 DOI: https://doi.org/10.3892/mmr.2020.10982

Zhao, J., Sun, Y., Sheng, X., Xu, J., Dai, G., He, R., Jin, Y., Liu, Z., Xie, Y., Wu, T., Cao, Y., Hu, J., & Duan, C. (2023). Hypoxia-treated adipose mesenchymal stem cell-derived exosomes attenuate lumbar facet joint osteoarthritis. Molecular Medicine, 29(1). https://doi.org/10.1186/s10020-023-00709-3 DOI: https://doi.org/10.1186/s10020-023-00709-3

Zhao, S., Xiu, G., Wang, J., Wen, Y., Lu, J., Wu, B., Wang, G., Yang, D., Ling, B., Du, D., & Xu, J. (2023). Engineering exosomes derived from subcutaneous fat MSCs specially promote cartilage repair as miR-199a-3p delivery vehicles in Osteoarthritis. Journal of Nanobiotechnology, 21(1), 1–26. https://doi.org/10.1186/s12951-023-02086-9 DOI: https://doi.org/10.1186/s12951-023-02086-9

Zhou, H., Shen, X., Yan, C., Xiong, W., Ma, Z., Tan, Z., Wang, J., Li, Y., Liu, J., Duan, A., & Liu, F. (2022). Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage. Stem Cell Research and Therapy, 13(1), 1–21. https://doi.org/10.1186/S13287-022-03005-9/FIGURES/9 DOI: https://doi.org/10.1186/s13287-022-03005-9

Zhou, X., Liang, H., Hu, X., An, J. N., Ding, S., Yu, S., Liu, C., Li, F., & Xu, Y. (2020). BMSC-derived exosomes from congenital polydactyly tissue alleviate osteoarthritis by promoting chondrocyte proliferation. Cell Death Discovery, 6(1). https://doi.org/10.1038/s41420-020-00374-z DOI: https://doi.org/10.1038/s41420-020-00374-z

Zhu, Y., Wang, Y., Zhao, B., Niu, X., Hu, B., Li, Q., Zhang, J., Ding, J., Chen, Y., & Wang, Y. (2017). Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis. Stem Cell Research and Therapy, 8(1), 1–11. https://doi.org/10.1186/s13287-017-0510-9 DOI: https://doi.org/10.1186/s13287-017-0510-9

Extracellular vesicles and their translational therapeutic potential

Original scientific article

Authors

DOI:

Keywords:

Abstract

Downloads

References

Downloads

Published

Issue

Section

License

How to Cite

Funding data

Most read articles by the same author(s)

JIF

elsevier

links

Information